Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: Three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesisREMSING, Lily L; GONZALEZ, Ana M; NUR-E-ALAM, Mohammad et al.Journal of the American Chemical Society. 2003, Vol 125, Num 19, pp 5745-5753, issn 0002-7863, 9 p.Article

Identification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycinBEAULIEU, E; GREEN, L; ELSBY, L et al.Clinical and experimental immunology (Print). 2011, Vol 163, Num 2, pp 178-188, issn 0009-9104, 11 p.Article

Acquired dysfibrinogenemia secondary to mithramycin toxicityASHBY, M. A; LAZARCHICK, J.The American journal of the medical sciences. 1986, Vol 292, Num 1, pp 53-55, issn 0002-9629Article

Combining Betulinic Acid and Mithramycin A Effectively Suppresses Pancreatic Cancer by Inhibiting Proliferation, Invasion, and AngiogenesisYONG GAO; ZHILIANG JIA; KEPING XIE et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 15, pp 5182-5193, issn 0008-5472, 12 p.Article

Differential inhibition of restriction enzyme cleavage by chromophore-modified analogues of the antitumour antibiotics mithramycin and chromomycin reveals structure-activity relationshipsMANSILLA, Sylvia; GARCIA-FERRER, Irene; MENDEZ, Carmen et al.Biochemical pharmacology. 2010, Vol 79, Num 10, pp 1418-1427, issn 0006-2952, 10 p.Article

Inhibition of collagen gene expression in systemic sclerosis dermal fibroblasts by mithramycinSANDORFI, N; LOUNEVA, N; HITRAYA, E et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 12, pp 1685-1691, issn 0003-4967, 7 p.Article

Insertional inactivation of mtrX and mtrY genes from the mithramycin gene cluster affects production and growth of the producer organism Streptomyces argillaceusGARCIA-BERNARDO, J; BRANA, A. F; MENDEZ, C et al.FEMS microbiology letters. 2000, Vol 186, Num 1, pp 61-65, issn 0378-1097Article

Syndrome hémorragique mortel après methramycine: inagrégabilité plaquettaire et inhibiteur du facteur V = Lethal haemorrhagic syndrome following mithramycin therapy. Lock of platelet aggregation and presence of factor V inhibitorTHOMAS, F; ROBERT, A; LUQUEL, L et al.La Presse médicale (1983). 1989, Vol 18, Num 4, issn 0755-4982, 182Article

Low-dose mithramycin exerts its anticancer effect via the p53 signaling pathway and synergizes with nutlin-3 in gynecologic cancersOHGAMI, Tatsuhiro; KATO, Kiyoko; KOBAYASHI, Hiroaki et al.Cancer science. 2010, Vol 101, Num 6, pp 1387-1395, issn 1347-9032, 9 p.Article

GC-selective DNA-binding antibiotic, Mithramycin A, reveals multiple points of control in the regulation of Hdm2 protein synthesisPHILLIPS, A; DARLEY, M; BLAYDES, J. P et al.Oncogene (Basingstoke). 2006, Vol 25, Num 30, pp 4183-4193, issn 0950-9232, 11 p.Article

Chemotherapeutic stress mediated by certain antitumor antibiotics induces an atypical CD69⁺ surface phenotype in peripheral T-lymphocytesMORGAN, C. D; HOLGUIN, M. H.International immunopharmacology. 2002, Vol 2, Num 2-3, pp 367-380, issn 1567-5769Article

Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin AZHILIANG JIA; JUN ZHANG; DAOYAN WEI et al.Cancer research (Baltimore). 2007, Vol 67, Num 10, pp 4878-4885, issn 0008-5472, 8 p.Article

Characterization of kinetics and products of the baeyer-villiger oxygenase mtmOIV, the key enzyme of the biosynthetic pathway toward the natural product anticancer drug mithramycin from Streptomyces argillaceusGIBSON, Miranda; NUR-E-ALAM, Mohammad; LIPATA, Fredilyn et al.Journal of the American Chemical Society. 2005, Vol 127, Num 50, pp 17594-17595, issn 0002-7863, 2 p.Article

Sequence-selective DNA binding drugs mithramycin A and chromomycin A₃ are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neuronsCHATTERJEE, Sukalyan; ZAMAN, Khalequz; RYU, Hoon et al.Annals of neurology. 2001, Vol 49, Num 3, pp 345-354, issn 0364-5134Article

Neutrophil elastase stimulates MUC1 gene expression through increased Spl binding to the MUC1 promoterKUWAHARA, Ippei; LILLEHOJ, Erik P; HISATSUNE, Akinori et al.American journal of physiology. Lung cellular and molecular physiology. 2005, Vol 33, Num 2, pp L355-L362, issn 1040-0605Article

Membrane interaction of an antitumor antibiotic, mithramycin, with anionic phospholipid vesiclesMAJEE, S; CHAKRABARTI, A.Biochemical pharmacology. 1999, Vol 57, Num 9, pp 981-987, issn 0006-2952Article

The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cellsBIANCHI, N; OSTI, F; RUTIGLIANO, C et al.British journal of haematology. 1999, Vol 104, Num 2, pp 258-265, issn 0007-1048Article

A pilot study of alpha-interferon and plicamycin for accelerated phase of chronic myeloid leukemiaDUTCHER, J. P; COLETTI, D; PAIETTA, E et al.Leukemia research. 1997, Vol 21, Num 5, pp 375-380, issn 0145-2126Article

Protective action of mithramycin against neurodegeneration and impairment of synaptic plasticity in the hippocampal CA1 area after transient global ischemiaOSADA, Nobuhiro; KOSUGE, Yasuhiro; OGUCHI, Sayuri et al.Neurochemistry international. 2012, Vol 60, Num 1, pp 47-54, issn 0197-0186, 8 p.Article

Spectrophotometric study of mithramycin complexes with Cu(II), Fe(III) and Tb(III)PEREIRA, M. A; DE FIGUEIREDO, T. L; DEMICHELI, C et al.Analytical letters. 1997, Vol 30, Num 14, pp 2555-2563, issn 0003-2719Article

Tumor necrosis factor-α induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-α-induced fractalkine expressionSO YOUNG AHN; CHO, Chung-Hyun; PARK, Keun-Gyu et al.The American journal of pathology. 2004, Vol 164, Num 5, pp 1663-1672, issn 0002-9440, 10 p.Article

High resolution hydroxyl radical footprinting of the binding of mithramycin and related antibiotics to DNACONS, B. M. G; FOX, K. R.Nucleic acids research. 1989, Vol 17, Num 14, pp 5447-5459, issn 0305-1048, 13 p.Article

Décès après administration de mithramycine = Death after mithramycin administrationSOUFARAPIS, H; SUISSE, A; CHARLET, P et al.Cahiers d'anesthésiologie (Paris). 1988, Vol 36, Num 7, pp 567-569, issn 0007-9685Article

Enzyme immunoassay for the quantification of mithramycin using β-D-galactosidase as a labelFUJIWARA, K; SAITA, T; NAKASHIMA, K et al.Cancer research (Baltimore). 1986, Vol 46, Num 3, pp 1084-1088, issn 0008-5472Article

Species-specific differences in the toxicity and mutagenicity of ther antiancer drugs mithramycin, chromomycin A₃, and olivomycinSINGH, B; GUPTA, R. S.Cancer research (Baltimore). 1985, Vol 45, Num 6, pp 2813-2820, issn 0008-5472Article